Testing indocyanine green dye to spot the ureter during endometriosis surgery
Tests indocyanine green dye to help find the ureter during robot-assisted surgery for advanced endometriosis.
Key facts
- Who runs it
- Baylor College of Medicine
- Where
- Houston, United StatesSee the site
- Trial code
- Registry title
- Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 40 people, planned
- Started
- 1 Oct 2025
- Planned end
- 15 Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Indocyanine Green (ICG)-Assisted Ureteral Identification
- Standard Ureteral Identification without ICG
- Record updated
- 28 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with advanced endometriosis who are planned for robotic surgery to remove it. It tests a green dye (indocyanine green) to help the surgeon see the ureter during the operation.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Stage III or IV endometriosis (rASRM classification)
- Earlier treatment
- Planned robotic transabdominal endometriosis excision, with or without hysterectomy
Main reasons for not taking part
- Younger than 18 years old
- Pregnant
- Prisoners
- Mental disabilities or cognitive impairment
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Stage III or IV endometriosis (rASRM classification)
- Planned robotic transabdominal endometriosis excision with or without hysterectomy
Who cannot take part
- Subjects who are part of a vulnerable population will be excluded including those who are prisoners, younger than 18 years old, pregnant, individuals with mental disabilities or cognitive impairment
Where in United States
- Texas Childrens Hospital Pavilion for WomenHouston, United StatesContact: Xiaoming Guan, PhD, MDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this side-randomized, self-controlled trial, 1-site study is to explore the efficacy of Indocyanine Green Fluorescence (ICG) for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis.
Read full original descriptionShow less
Researchers will perform temporary ureteral stent using indocyanine green fluorescence for intraoperative ureteral identification on either the left or right side of subjects who are undergoing a robotic assisted transumbilical resection of advanced endometriosis.
Participants will be randomized to receive ICG-assisted ureteral identification on either the left or right side. Randomization will be conducted using a computer-generated block randomization method.
The primary aim is to determine whether ICG-assisted ureter visualization can reduce operative time for endometriosis resection and ureterolysis, and minimize the risk of ureteral injury.
Secondary objectives are to assess the feasibility and safety of temporary ureteral ICG stenting for intraoperative ureter identification in advanced endometriosis.
The 2 groups in the trial
- Arm A: ICG-Assisted Ureteral Identification (Unilateral)Treatment being tested
Participants assigned to this study will undergo intraoperative ureteral identification using indocyanine green (ICG) fluorescence imaging in either left or right side. A temporary ureteral stent will be inserted on the randomized side (left or right) prior to ureterolysis and endometriosis resection. ICG will be administered through the stent to facilitate real-time fluorescence visualization of the ureter during robot-assisted single-site surgery. The contralateral side will serve as the control arm (standard visualization without ICG).
Treatment: Indocyanine Green (ICG)-Assisted Ureteral Identification
- Arm B: Standard Visualization (Contralateral Control)Existing treatment, for comparison
Participants assigned to this study will undergo intraoperative ureteral identification using indocyanine green (ICG) fluorescence imaging in either left or right side. A temporary ureteral stent will be inserted on the randomized side (left or right) prior to ureterolysis and endometriosis resection. ICG will be administered through the stent to facilitate real-time fluorescence visualization of the ureter during robot-assisted single-site surgery. The contralateral side will serve as the control arm (standard visualization without ICG).
Treatment: Standard Ureteral Identification without ICG
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Side-Randomized, Self-Controlled Trial Assessing the Efficacy of Indocyanine Green Fluorescence Imaging for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis
- Plain-language title
- Testing indocyanine green dye to spot the ureter during endometriosis surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 August 2025